Health Canada
- Status: approved
🇨🇦 Bay Ntn 33893 in Canada
Bay Ntn 33893 (imidacloprid) regulatory status in Canada.
Marketing authorisation
Bay Ntn 33893 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Canada
Frequently asked questions
Is Bay Ntn 33893 approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Bay Ntn 33893 in Canada?
Marketing authorisation holder not available in our data.